Sign in

    ICU Medical Inc (ICUI)

    Updated May 8, 2025, 11:07 PM UTC
    Income Statement - MetricQ1 2022Q2 2022Q3 2022Q4 2022FY 2022Q1 2023Q2 2023Q3 2023Q4 2023FY 2023Q1 2024Q2 2024Q3 2024Q4 2024FY 2024Q1 2025
    Total Revenues (USD, thousands)587,856.002,259,126566,655596,455.00589,131.00629,805.002,382,046604,702
    Cost of Goods Sold (USD, thousands)416,271.001,519,253381,411389,027.00384,279.00402,547.001,557,264394,593
    Gross Profit (USD, thousands)171,585.00739,873185,244207,428.00204,852.00227,258.00824,782210,109
    Selling, General and Administrative Expenses (USD, thousands)154,617.00606,693157,657159,549.00162,707.00158,849.00638,762157,233
    Research and Development Expenses (USD, thousands)22,411.0085,34421,84223,390.0021,028.0022,355.0088,61523,291
    Restructuring, Strategic Transaction and Integration Expenses (USD, thousands)10,731.0041,25816,10517,136.0016,828.009,771.0059,84016,697
    Change in Fair Value of Contingent Earn-Out (USD, thousands)(3,991.00)(16,247)295(339.00)(3,947.00)(1,408.00)(5,399)0
    Total Operating Expenses (USD, thousands)183,768.00717,048195,899199,736.00196,616.00189,567.00781,818197,221
    Income (Loss) from Operations (USD, thousands)(12,183.00)22,825(10,655)7,692.008,236.0037,691.0042,96412,888
    Interest Expense, Net (USD, thousands)(24,408.00)(95,219)(23,772)(23,841.00)(24,683.00)(23,457.00)(95,753)(22,031)
    Other Expense, Net (USD, thousands)(90.00)(5,905)(2,341)(3,384.00)(1,481.00)(6,017.00)(13,223)(1,763)
    Loss Before Income Taxes (USD, thousands)(36,681.00)(78,299)(36,768)(19,533.00)(17,928.00)8,217.00(66,012)(10,906)
    (Provision) Benefit for Income Taxes (USD, thousands)19,534.0048,644(2,703)(1,873.00)(15,055.00)(32,045.00)(51,676)(4,570)
    Net Loss (USD, thousands)(17,147.00)(29,655)(39,471)(21,406.00)(32,983.00)(23,828.00)(117,688)(15,476)
    Net Loss per Share Basic (USD)(0.71)(1.23)(1.63)(0.88)(1.34)(0.98)(4.83)(0.63)
    Net Loss per Share Diluted (USD)(0.71)(1.23)(1.63)(0.88)(1.34)(0.98)(4.83)(0.63)
    Weighted Average Number of Shares Basic (Thousands)16.0024,09124,22273.0058.0035.0024,38824,539
    Weighted Average Number of Shares Diluted (Thousands)16.0024,09124,22273.0058.0035.0024,38824,539
    Balance Sheet - MetricQ1 2022Q2 2022Q3 2022Q4 2022FY 2022Q1 2023Q2 2023Q3 2023Q4 2023FY 2023Q1 2024Q2 2024Q3 2024Q4 2024FY 2024Q1 2025
    Cash and cash equivalents (USD, thousands)254,222254,222251,423302,648312,512308,566308,566289,704
    Short-term investment securities (USD, thousands)501501------
    TOTAL CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENT SECURITIES (USD, thousands)254,723254,723251,423302,648312,512308,566308,566289,704
    Accounts receivable, net (USD, thousands)161,566161,566145,186151,765173,983182,828182,828170,928
    Inventories (USD, thousands)709,360709,360693,006682,870692,038584,676584,676590,326
    Prepaid income taxes (USD, thousands)21,98321,98315,47617,8835,78711,24411,24411,471
    Prepaid expenses and other current assets (USD, thousands)73,64073,64082,63680,82573,73570,28770,28775,364
    Assets held for sale (USD, thousands)-----284,382284,382286,122
    TOTAL CURRENT ASSETS (USD, thousands)1,221,2721,221,2721,187,7271,235,9911,258,0551,441,9831,441,9831,423,915
    PROPERTY, PLANT AND EQUIPMENT, net (USD, thousands)612,909612,909602,617594,085595,627442,746442,746441,983
    OPERATING LEASE RIGHT-OF-USE ASSETS (USD, thousands)69,90969,90964,92866,40859,75753,29553,29558,025
    GOODWILL (USD, thousands)1,472,4461,472,4461,459,3681,450,9351,478,2931,432,7721,432,7721,455,113
    INTANGIBLE ASSETS, net (USD, thousands)870,588870,588836,904805,794785,823740,789740,789716,667
    DEFERRED INCOME TAXES - Assets (USD, thousands)37,29537,29540,20338,86140,64624,21124,21124,247
    OTHER ASSETS - Assets (USD, thousands)94,02094,02096,65194,59386,83768,13568,13564,631
    TOTAL ASSETS (USD, thousands)4,378,4394,378,4394,288,3984,286,6674,305,0384,203,9314,203,9314,184,581
    Accounts payable (USD, thousands)150,030150,030152,480155,515168,562148,020148,020180,409
    Accrued liabilities (USD, thousands)268,215268,215247,896299,751325,728306,923306,923278,892
    Current portion of long-term debt (USD, thousands)51,00051,00051,00051,00051,00051,00051,00047,813
    Income tax payable (USD, thousands)7,7147,7142,4844,1412,76717,32817,32812,246
    Liabilities held for sale (USD, thousands)-----32,91132,91129,664
    TOTAL CURRENT LIABILITIES (USD, thousands)481,838481,838455,360511,907549,557556,182556,182549,024
    LONG-TERM DEBT (USD, thousands)1,577,7701,577,7701,566,2981,554,8221,543,3421,531,8581,531,8581,488,565
    OTHER LONG-TERM LIABILITIES (USD, thousands)100,497100,497102,59491,35680,38966,74566,74577,637
    DEFERRED INCOME TAXES - Liabilities (USD, thousands)55,87355,87355,58553,79448,53848,81448,81445,493
    INCOME TAX LIABILITY (USD, thousands)35,06035,06036,44533,02934,62535,09735,09736,173
    Common stock, $ 0.10 par value (USD, thousands)2,4142,4142,4412,4432,4462,4522,4522,461
    Additional paid-in capital (USD, thousands)1,366,4931,366,4931,371,2441,380,7031,394,7991,412,1181,412,1181,416,001
    Treasury stock, at cost (USD, thousands)(262)(262)(4,692)(518)(208)(92)(92)(60)
    Retained earnings (USD, thousands)807,846807,846768,375746,969713,986690,158690,158674,682
    Accumulated other comprehensive loss (USD, thousands)(53,081)(53,081)(69,538)(91,785)(62,436)(139,401)(139,401)(105,395)
    TOTAL STOCKHOLDERS' EQUITY (USD, thousands)2,123,4102,123,4102,067,8302,037,8122,048,5871,965,2351,965,2351,987,689
    TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (USD, thousands)4,378,4394,378,4394,288,3984,286,6674,305,0384,203,9314,203,9314,184,581
    Cash Flow - MetricQ1 2022Q2 2022Q3 2022Q4 2022FY 2022Q1 2023Q2 2023Q3 2023Q4 2023FY 2023Q1 2024Q2 2024Q3 2024Q4 2024FY 2024Q1 2025
    Net Loss (USD, thousands)(17,147.00)(29,655)(39,471)(21,406.00)(32,983.00)(23,828.00)(117,688)(15,476)
    Depreciation and Amortization (USD, thousands)57,159.00228,77455,52655,318.0055,675.0052,993.00219,51249,445
    Noncash Lease Expense (USD, thousands)5,367.0021,9105,3415,183.005,484.005,336.0021,3444,475
    Provision for Doubtful Accounts (USD, thousands)(27.00)838549821.0011.004,419.005,800-
    Provision for Warranty and Returns (USD, thousands)15,985.0021,582(618)(1,840.00)4,259.00(671.00)1,1303,634
    Stock Compensation (USD, thousands)10,685.0040,56311,59810,998.0011,770.0012,517.0046,88312,179
    Loss on Disposal or Write-off of Property, Plant and Equipment (USD, thousands)352.002,109(65)(13.00)262.002,338.002,5221,696
    Debt Issuance Cost Amortization (USD, thousands)1,706.006,8141,7081,703.001,700.001,696.006,8071,700
    Change in Fair Value of Contingent Earn-Out (USD, thousands)(3,991.00)(16,247)295(339.00)(3,947.00)(1,408.00)(5,399)-
    Usage of Spare Parts (USD, thousands)3,463.0017,0504,2014,743.005,021.004,333.0018,2985,023
    Other Operating Activities (USD, thousands)3,656.008,0492,6272,298.002,331.00137.007,393557
    Accounts Receivable (Change) (USD, thousands)5,549.0048,63513,967(7,252.00)(18,232.00)(35,327.00)(46,844)22,439
    Inventories (Change) (USD, thousands)60,583.00(6,079)14,1646,931.00(11,679.00)7,413.0016,829(8,224)
    Prepaid Expenses and Other Current Assets (Change) (USD, thousands)377.0011,672(5,735)(6,903.00)1,450.002,359.00(8,829)(8,464)
    Other Assets (Change) (USD, thousands)(5,835.00)(24,695)(5,160)(5,964.00)(6,416.00)(5,614.00)(23,154)(6,815)
    Accounts Payable (Change) (USD, thousands)(3,252.00)(68,301)5,3134,119.0011,654.00(8,555.00)12,53132,099
    Accrued Liabilities (Change) (USD, thousands)(3,947.00)(14,479)(16,503)36,748.00239.00184.0020,668(36,343)
    Income Taxes, Including Excess Tax Benefits and Deferred Income Taxes (USD, thousands)(39,417.00)(82,356)(1,946)(3,192.00)9,498.0021,870.0026,230(6,598)
    Net Cash Provided by (Used in) Operating Activities (USD, thousands)91,269.00166,20145,79181,953.0036,097.0040,192.00204,03351,327
    Purchases of Property, Plant and Equipment (USD, thousands)(29,937.00)(83,893)(15,915)(19,467.00)(19,910.00)(24,081.00)(79,373)(14,621)
    Proceeds from Sale of Assets (Investing) (USD, thousands)20.001,501507185.003.0051.0074642
    Intangible Asset Additions (USD, thousands)(2,035.00)(9,777)(2,954)(2,410.00)(2,953.00)(2,516.00)(10,833)(2,232)
    Proceeds from Sale of Investment Securities (USD, thousands)1,302.004,2225000.000.000.00500-
    Net Cash Used in Investing Activities (USD, thousands)(30,650.00)(87,947)(17,862)(21,692.00)(22,860.00)(26,546.00)(88,960)(16,811)
    Principal Repayments of Long-Term Debt (USD, thousands)(7,438.00)(29,688)(12,750)(12,750.00)(12,750.00)(12,750.00)(51,000)(47,750)
    Proceeds from Exercise of Stock Options (USD, thousands)0.004,0221502,924.002,809.005,056.0010,939133
    Payments on Finance Leases (USD, thousands)(282.00)(963)(245)(273.00)(257.00)(372.00)(1,147)(328)
    Payment of Contingent Earn-Out (USD, thousands)--(2,600)0.000.000.00(2,600)-
    Tax Withholding Payments Related to Net Share Settlement of Equity Awards (USD, thousands)(129.00)(9,350)(11,400)(285.00)(182.00)(125.00)(11,992)(8,391)
    Net Cash (Used in) Provided by Financing Activities (USD, thousands)(7,849.00)(35,979)(26,845)(10,384.00)(10,380.00)(8,191.00)(55,800)(56,336)
    Effect of Exchange Rate Changes on Cash (USD, thousands)4,260.003,163(3,883)1,348.007,007.00(9,401.00)(4,929)2,958
    Net Increase (Decrease) in Cash and Cash Equivalents (USD, thousands)57,030.0045,438(2,799)51,225.009,864.00(3,946.00)54,344(18,862)
    Cash and Cash Equivalents, Beginning of Period (USD, thousands)208,784208,784254,222254,222254,222254,222254,222308,566
    Cash and Cash Equivalents, End of Period (USD, thousands)254,222254,222251,423302,648312,512308,566308,566289,704
    Revenue by Segment - in Millions of USDQ1 2022Q2 2022Q3 2022Q4 2022FY 2022Q1 2023Q2 2023Q3 2023Q4 2023FY 2023Q1 2024Q2 2024Q3 2024Q4 2024FY 2024Q1 2025
    Consumables254969.1244.0261.8264.9268.21,038.9266.226
    - GAAP Revenue168.7661.0165.3-----
    - Constant Currency Revenue-665.5166.2-164.6--269.2
    Infusion Systems165.1629.0157.3163.7159.8171.6652.4166.300
    Vital Care168.7661.0165.3171.0164.519690.8172.176
    Total Revenue587.92,259.1566.7596.5589.1629.72,382.0604.702
    Revenue by Geography - in Millions of USDQ1 2022Q2 2022Q3 2022Q4 2022FY 2022Q1 2023Q2 2023Q3 2023Q4 2023FY 2023Q1 2024Q2 2024Q3 2024Q4 2024FY 2024Q1 2025
    United States376.971440.000366.155383.14369.5413.31,532.1388.245
    Europe, the Middle East, and Africa96.61373.60098.38995.31101.798.1393.595.688
    Asia-Pacific63.98241.70051.85361.2260.359.43232.859.411
    Other Foreign50.28203.80050.25856.7857.658.96223.661.358
    - Canada--------
    - Latin America (LATAM)--------
    Total Revenue587.832259.100566.655596.46589.1629.782,382.0604.702